United States Securities and Exchange Commission · EDGAR Accession 0001429819-26-000001

Form C-U

Offering Progress Update — Regulation Crowdfunding
Campaign file 020-36429
Issuer CIK 1429819
Raising via StartEngine Primary, LLC

CALOSYN PHARMA, INC.

CorporationDEIncorporated 2007SHREVEPORT, LAcalosyn.com
Progress updateAt the close of the offering, the issuer closed on $126,903.04 and 0 number of securities.
A

The Offering

as disclosed in this filing
Other (Convertible Note)
$20,000
$1,235,000
February 27, 2026
Expired 107 days ago
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn decreasingDebt / assets 1704%3 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(637,680)(767,511)▲ burn
Total assets164,279154,570▲ 6%
Cash & equivalents147,320136,426▲ 8%
Accounts receivable00
Short-term debt436,182348,029▲ 25%
Long-term debt2,363,2471,817,403▲ 30%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36429 · all filings under this campaign
Loading campaign history…